Switching patients with acromegaly from octreotide LAR to pasireotide LAR improves biochemical control: Crossover extension to a randomized, double-blind, multicenter, phase III study

Authors
Category Primary study
JournalEndocrine Reviews
Year 2012
This article has no abstract
Epistemonikos ID: 48f235785eb50dfb03d26f314da3db30bc9f2a67
First added on: Feb 05, 2025